Rasonque

Revolution's stock soared after the US Food and Drug Administration (FDA) approved its revolutionary drug. Will the drug reach Israel, how much will it cost, what will insurance companies do, and what competing products are on the market? Here are the answers.

The US Food and Drug Administration (FDA) has approved a new drug, Rasonque, for the treatment of advanced pancreatic cancer. Experts believe this development could significantly improve outcomes for patients facing this deadly disease.